Arkolith/Insider Trading/VKTX/Form 4

Lian Brian

President & CEO, DirectorViking Therapeutics, Inc. (VKTX) · full profile →Form 4 · filed Jan 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7.7M
Net Open-Market Flow
-$7.7M
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2026Sell(S)41K$34.22$1.4M2.5M
Jan 5, 2026Sell(S)6K$35.07$224K2.5M
Jan 5, 2026Sell(S)53K$33.38$1.8M2.5M
Jan 5, 2026Sell(S)132K$32.29$4.3M2.6M
Jan 2, 2026Grant(A)78K—$02.5M
Jan 2, 2026Grant(A)224K—$02.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 2, 2026Grant(A)176K—$0176K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-003113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML